Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:21 PM
Ignite Modification Date:
2025-12-24 @ 4:21 PM
NCT ID:
NCT03193866
Eligibility Criteria:
INCLUSION CRITERIA:
The study population consists of all patients with Clinically Isolated Syndrome (CIS) or RRMS who;
* Initiate a first MS DMT (treatment naïve), or Initiate a second ever DMT, of a different drug class than the first, regardless of time between drugs or reason for discontinuation("switchers") from 1st Jan 2011 to 30st June 2018, and
* Are followed at any of the University clinics of Sweden, and
* Consent to participation in COMBAT-MS core, and
* Are expected to be capable to follow study assessments.
EXCLUSION CRITERIA:
\- Patients with progressive forms of MS at start of therapy are not eligible
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03193866
Study Brief:
Protocol Section:
NCT03193866